Hims & Hers Health, Inc. reported a strong first quarter in 2021, with revenue increasing by 74% year-over-year to $52.3 million. The company's gross margin improved to 77%, and it ended the quarter with 391,000 subscriptions, up nearly 80% year-over-year. However, the net loss increased to $(51.4) million due to one-time stock-based compensation and transaction bonus expenses related to the merger.
Revenue increased by 74% year-over-year to $52.3 million.
Gross margin improved to 77% compared to 69% in the first quarter of 2020.
The company ended the quarter with 391,000 subscriptions, up nearly 80% year-over-year.
Net loss was $(51.4) million, primarily driven by one-time stock-based compensation and transaction bonus expenses related to the merger.
Hims & Hers provides revenue and Adjusted EBITDA guidance for Q2 2021 and full year 2021.
Visualization of income flow from segment revenue to net income